High-risk myelodysplastic syndrome stem cells rely heavily on the molecule NAD for energy, and disrupting that pathway selectively weakens the cancer-driving cells, pointing to a possible new treatment target.
Cancer Stem Cells Show NAD Energy Dependence in High-Risk MDS
High-risk myelodysplastic syndrome stem cells rely heavily on the molecule NAD for energy, and disrupting that pathway selectively weakens the cancer-driving cells, pointing to a possible new treatment target.
Cancer stem cell · Wikimedia — licence per file · rights
This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.
Monitoring item. The full text is not distributed. Extract and source below.